DREADD AGONIST 21

DREADD AGONIST 21

中文名称DREADD AGONIST 21
中文同义词DREADD激动剂21;化合物DREADD AGONIST 21;11-(哌嗪-1-基)-5H-二苯并[B,E][1,4]二氮杂卓
英文名称11-Piperazinyldibenzo[b,e][1,4]diazepine
英文同义词11-Piperazinyldibenzo[b,e][1,4]diazepine;DREADD Agonist 21;11-(1-Piperazinyl)-5H-dibenzo[b,e][1,4]diazepine;DREADD agonist 1;5H-Dibenzo[b,e][1,4]diazepine, 11-(1-piperazinyl)-;Muscarinic acetylcholine receptor,schizophrenia,mAChR,Inhibitor,muscarinic,disease,inhibit,DREADD agonist21,neurodegenerative,acetylcholine,DREADD agonist 21,DREADD,neuronal,hM3Dq,DREADD agonist-21,activation,receptors;11-(Piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
CAS号56296-18-5
分子式C17H18N4
分子量278.35
EINECS号
相关类别杂环,中间体;合成材料中间体
Mol文件56296-18-5.mol
结构式DREADD AGONIST 21 结构式

DREADD AGONIST 21 性质

沸点470.1±55.0 °C(Predicted)
密度1.28±0.1 g/cm3(Predicted)
储存条件Store at -20°C
溶解度DMSO:PBS (pH 7.2) (1:1):0.5(最大浓度 mg/mL);1.8(最大浓度 mM)
乙醇:29.61(最大浓度 mg/mL);106.39(最大浓度。 mM)
形态结晶固体
酸度系数(pKa)8.56±0.10(Predicted)
颜色粘黄色

DREADD AGONIST 21 用途与合成方法

DREADD agonist 21 是一种有效的 human muscarinic acetylcholine M3 receptors (hM3Dq) 激动剂,其EC50值为1.7 nM。
TargetValue
hM3Dq
(Cell-free assay)
1.7 nM(EC50)

DREADD agonist 21 is a potent human muscarinic acetylcholine M3 receptors (hM3Dq) agonist (EC 50 =1.7 nM) and does not activate human M3 receptor (hM3). In addition to being inactive at hM3, DREADD agonist 21, a potent full agonist of hM3Dq (EC 50 =1.7 nM), is only 3.5-fold selective for hM3Dq over H1, 40-fold selective over 5HT2A, 100-fold selective over 5HT2C, and 165-fold selective over α1A. DREADD agonist 21 shows high binding affinities to 5HT2A and 5HT2C serotonin receptor, α1A adrenergic receptor, and H1 histamine receptor with K i values of 66, 170, 280, and 6 nM, respectively.
DREADD agonist 21 potently activates hM1Dq, hM3Dq, and hM4Di. DREADD agonist 21 binds to hM1, hM4, hM1Dq and hM4Di receptors with pK i s of 5.97, 5.44, 7.20, and 6.75, respectively. DREADD agonist 21 potently activates hM3Dq in Chinese hamster ovary (CHO) cells transfected cells in vitro with a pEC 50 of 8.48±0.05. DREADD agonist 21 is a highly selective and potent agonist for muscarinic DREADDs (pEC 50 for hM1Dq=6.54 and that for hM4Di=7.77 in pERK assays).

DREADD agonist 21 (0.3, 1.0, and 3.0 mg/kg; i.p.) activates neuronal hM3Dq in mice.
DREADD agonist 21 has excellent bioavailability, pharmacokinetic properties, and brain penetrability. DREADD agonist 21 (0.1, 1, and 10 mg/kg; i.p.) displays 95.1% plasma protein binding and 95% brain protein bounding in mice.

安全信息

MSDS信息

更新日期产品编号产品名称CAS号包装价格
2024/04/30HY-100234DREADD AGONIST 21
DREADD agonist 21
56296-18-52mg600元
2024/04/30HY-100234DREADD AGONIST 21
DREADD agonist 21
56296-18-510mM * 1mLin DMSO920元

DREADD AGONIST 21 上下游产品信息

"DREADD AGONIST 21"相关产品信息
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 | 评选活动 | HS海关编码 | MSDS查询 | 化工站点

Copyright © 2016-2023 ChemicalBook 版权所有  京ICP备07040585号  京公海网安备11010802032676号  

互联网增值电信业务经营许可证:京ICP证150597号  互联网药品信息服务资格证编号(京)-非经营性-2015-0073  信息系统安全等级保护备案证明(三级)  营业执照公示

根据相关法律法规和本站规定,单位或个人购买相关危险物品应取得有效的资质、资格条件。
参考《应急管理部等多部门关于加强互联网销售危险化学品安全管理的通知 (应急〔2022〕119号)》《互联网危险物品信息发布管理规定》